Amgen Inc. buy Piper Jaffray Companies
Start price
02.01.25
/
50%
€254.50
Target price
02.01.26
€300.51
Performance (%)
8.92%
End price
03.01.26
€277.20
Summary
This prediction ended on 03.01.26 with a price of €277.20. With a performance of 8.92%, the BUY prediction by Piper_Jaffray_Compan for Amgen Inc. closed with a slight gain. Dividends of €9.41 are taken into consideration when calculating the performance. Piper_Jaffray_Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | -1.652% | -1.652% | 8.331% |
| iShares Core DAX® | -3.520% | -4.987% | 1.926% |
| iShares Nasdaq 100 | 0.261% | 1.102% | 15.434% |
| iShares Nikkei 225® | -4.953% | -3.352% | 29.010% |
| iShares S&P 500 | -0.823% | -0.042% | 10.814% |
Comments by Piper_Jaffray_Compan for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its "overweight" rating re-affirmed by analysts at Piper Sandler Companies. They now have a $310.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Piper_Jaffray_Compan gewählte maximale Laufzeit wurde überschritten